4//SEC Filing
Eisele Jeffrey 4
Accession 0001127602-23-030552
CIK 0001492422other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 4:13 PM ET
Size
6.1 KB
Accession
0001127602-23-030552
Insider Transaction Report
Form 4
Eisele Jeffrey
Chief Development Officer
Transactions
- Sale
Common Stock
2023-12-27$60.23/sh−235$14,154→ 53,580 total - Sale
Common Stock
2023-12-26$57.86/sh−68$3,935→ 53,815 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on a Restricted Stock Unit release.
- [F2]Sale originated from established 10b5-1 trading plan.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001827326
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 4:13 PM ET
- Size
- 6.1 KB